April 2023 marks five years since Medicines Discovery Catapult (MDC), an independent, not-for-profit national innovation centre for drug discovery, actively began reshaping drug discovery for patient benefit.
To mark this milestone, MDC has launched an impact showcase site, offering an immersive insight into a selection of MDC's work through the lens of its collaborations and initiatives.
From their base in Cheshire, MDC transforms great UK science into better treatments through partnerships. It has delivered over 230 projects with over 170 partners across the UK - helping UK companies…
In a move that will build on its leading position in the market and bring together experts across the business, Partners& has launched a national science and technology practice.
In line with the UK government’s commitment to focusing on the growth and development of this important part of our economy, Partners& is positioning itself to deliver a unique proposition to this complex, fast moving and innovative sector.
Led by Hanna Beaumont, Client Partner (Science & Tech), the Partners& team has rich experience and specialist insight into the challenges and risks inherent in…
Check out your monthly round up of employee engagement opportunities in this month's People Pathways newsletter!
Arecor Therapeutics plc
(“Arecor” or the “Group”)
US PATENT GRANTED PROTECTING PROPRIETARY FORMULATIONS OF MONOCLONAL ANTIBODIES
- Endorses potential of proprietary Arestat™ platform technology to invent novel, enhanced therapeutics in $210 billion monoclonal antibody market
- Further strengthens Group’s extensive patent portfolio
Cambridge, UK, 26 April 2023: Arecor Therapeutics plc (AIM: AREC), the biopharmaceutical group advancing today’s therapies to enable healthier lives, is pleased to announce that the United States Patent and Trademark Office has granted a patent (US11608357)…
ValiRx PLC, a life science company focused on early-stage cancer therapeutics and women’s health, has announced a collaborative services agreement between Physiomics PLC and ValiRx subsidiary company, Inaphaea BioLabs Ltd.
Based in Oxford, Physiomics is a leading oncology consultancy that uses mathematical models to support the development of cancer treatment regimens and personalised medicine solutions.
The agreement recognises the synergy between Inaphaea’s ambition to create a translational contract research organisation (tCRO™) and Physiomics’ capabilities across advanced statistical…
In this episode senior associate and patent attorney Paul Roscoe, and partner, solicitor and trade mark attorney Chris Hoole, are joined by 3D printing specialist and CEO/co-founder of Promake, Professor Jason Laing.
This episode will help manufacturers to understand the IP risks associated with 3D printing, how smart materials could provide anti-counterfeiting measures, and the direction of innovation in this technology area.
If you have any questions on this episode, IP in general, or would like to suggest a topic, please contact us at ip@appleyardlees.com.
Listen here: https://…
NRG Therapeutics Appoints Dr Jonathan Savidge as Independent Chair
Stevenage, UK, 26 April 2023 - NRG Therapeutics, Ltd., an innovative neuroscience company targeting mitochondrial dysfunction, is pleased to announce that it has appointed Jonathan Savidge Ph.D to its Board of Directors as independent Non-Executive Chair.
Jonathan’s appointment reflects the maturation of the company, having closed its series A financing of £16m in late 2022.
Jonathan brings over 20 years of experience in the biotech and pharma industries focused on strategic partnerships (investments, licensing, and M&A)…
Click here to view the April 2023 edition of The Meeting Place
• Agreement grants access to patient genotypes and clinical data curated by Professor Ammar Al-Chalabi’s Group based at King’s College London
• Motor Neurone Disease (MND) Association supports new analysis of patient data to bring cutting edge analysis tools to improve understanding of disease
• Enables PrecisionLife to establish precision neuroscience R&D partnerships to advance new patient stratification biomarkers, diagnostics and treatment approaches
Oxford and London, UK, 25 April 2023 – The techbio company PrecisionLife (http://www.precisionlife.com/) announces it has agreed a data…
Cambridge and Saffron Walden, UK, 21st April 2023 / Sciad Newswire / Domainex is honoured to announce it has received a King’s Award for Enterprise: International Trade 2023. This prestigious award recognises the company’s outstanding growth in international trade over three years (2019-2021) which amounted to a more than one hundred per cent increase in international revenues during the period. This growth was achieved organically, coincided with the challenging backdrop of the COVID-19 pandemic and is a testament to the company’s excellent reputation and commitment to delivering high-…